Zanon Zotin MC, Sveikata L, Viswanathan A, Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Curr Opin Neurol. 2021;34(2):246–57. https://doi.org/10.1097/WCO.00000000000000913.

Article  PubMed  PubMed Central  Google Scholar 

Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: A clinical review. Neurology. 2019;92(24):1146–56. https://doi.org/10.1212/WNL.0000000000007654.

Article  PubMed  PubMed Central  Google Scholar 

Markus HS, de Leeuw FE. Cerebral small vessel disease: Recent advances and future directions. Int J Stroke. 2023;18(1):4–14. https://doi.org/10.1177/17474930221144911.

Article  PubMed  PubMed Central  Google Scholar 

Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol. 2016;1(3):83–92. https://doi.org/10.1136/svn-2016-000035.

Article  PubMed  PubMed Central  Google Scholar 

Mu R, Qin X, Zheng W, Yang P, Huang B, Zhu X. Progressive brain structural abnormality in cerebral small vessel disease assessed with MR imaging by using causal network analysis. Neuroimage Clin. 2024;44:103672. https://doi.org/10.1016/j.nicl.2024.103672.

Article  PubMed  PubMed Central  Google Scholar 

iménez-Balado J, Riba-Llena I, Pizarro J, et al. Kidney function changes and their relation with the progression of cerebral small vessel disease and cognitive decline. J Neurol Sci. 2020;409:116635. https://doi.org/10.1016/j.jns.2019.116635.

Article  CAS  Google Scholar 

Hou L, Zhang S, Qi D, et al. Correlation between neutrophil/lymphocyte ratio and cognitive impairment in cerebral small vessel disease patients: A retrospective study. Front Neurol. 2022;13:925218. https://doi.org/10.3389/fneur.2022.925218.

Article  PubMed  PubMed Central  Google Scholar 

Hong Y, Zeng X, Zhu CW, et al. Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older Adults. J Geriatr Psychiatry Neurol. 2022;35(4):586–93. https://doi.org/10.1177/08919887211036182.

Article  PubMed  Google Scholar 

Climie RE, van Sloten TT, Bruno RM, et al. Macrovasculature and Microvasculature at the Crossroads Between Type 2 Diabetes Mellitus and. Hypertens Hypertens. 2019;73(6):1138–49. https://doi.org/10.1161/HYPERTENSIONAHA.118.11769.

Article  CAS  Google Scholar 

Rensma SP, van Sloten TT, Houben AJHM, et al. Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study. Hypertension. 2020;75(1):237–45. https://doi.org/10.1161/HYPERTENSIONAHA.119.13023.

Article  CAS  PubMed  Google Scholar 

Webb AJS, Werring DJ. New Insights Into Cerebrovascular Pathophysiology and Hypertension. Stroke. 2022;53(4):1054–64. https://doi.org/10.1161/STROKEAHA.121.035850.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Jong DLK, de Heus RAA, Rijpma A, et al. Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease. Hypertension. 2019;74(2):413–20. https://doi.org/10.1161/HYPERTENSIONAHA.119.12892.

Article  CAS  PubMed  Google Scholar 

Henley B, Okafor M, Kulshreshtha A, Trammell A, Hajjar I. Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials. Int J Stroke. 2023;18(6):736–44. https://doi.org/10.1177/17474930231153313.

Article  PubMed  PubMed Central  Google Scholar 

Rawlings AM, Sharrett AR, Albert MS, et al. The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study. Diabetes Care. 2019;42(7):1248–54. https://doi.org/10.2337/dc19-0120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alkethiri K, Almtroudi T, Jurays AB, et al. The relationship between type 2 diabetes mellitus with cognitive functions. Heliyon. 2021;7(3):e6358. https://doi.org/10.1016/j.heliyon.2021.e06358.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maan HB, Meo SA, Rouq FA, Meo IMU. Impact of Glycated Hemoglobin (HbA1c) on cognitive functions in Type 2 diabetic patients. Eur Rev Med Pharmacol Sci. 2021;25(19):5978–85. https://doi.org/10.26355/eurrev_202110_26875.

Article  CAS  PubMed  Google Scholar 

Alghadir AH, Gabr SA, Almomani M, Almomani F, Tse C. Adiponectin and Nitric Oxide Deficiency-Induced Cognitive Impairment in Fatigued Home-Resident in Mature and Older Adults: A Case-Control Study. Pain Res Manag. 2022;2022:7480579. https://doi.org/10.1155/2022/7480579.

Article  PubMed  PubMed Central  Google Scholar 

Brognara L, Volta I, Cassano VM, Navarro-Flores E, Cauli O. The Association between Cognitive Impairment and Diabetic Foot Care: Role of Neuropathy and Glycated Hemoglobin. Pathophysiology. 2020;27(1):14–27. https://doi.org/10.3390/pathophysiology27010003.

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Liu J, Wang F, et al. The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease. Front Aging Neurosci. 2023;15:1221548. https://doi.org/10.3389/fnagi.2023.1221548.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mijailovic NR, Vesic K, Borovcanin MM. The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction. Front Psychiatry. 2022;13:828476. https://doi.org/10.3389/fpsyt.2022.828476.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Gao Y, Song B, et al. Elevated Serum Homocysteine Associated with Distal Type of Single Small Subcortical Infarction. Curr Neurovasc Res. 2020;17(5):629–35. https://doi.org/10.2174/1567202617666201029145824.

Article  CAS  PubMed  Google Scholar 

Guéant JL, Guéant-Rodriguez RM, Oussalah A, Zuily S, Rosenberg I. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials. Thromb Haemost. 2023;123(3):270–82. https://doi.org/10.1055/a-1952-1946.

Article  PubMed  Google Scholar 

Wang T, Sun ZW, Shao LQ, et al. Diagnostic Values of Serum Levels of Homocysteine and Uric Acid for Predicting Vascular Mild Cognitive Impairment in Patients with Cerebral Small Vessel Disease. Med Sci Monit. 2017;23:2217–25. https://doi.org/10.12659/msm.901652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nair P, Misra S, Nath M, et al. Cystatin C and Risk of Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Dement Geriatr Cogn Disord. 2020;49(5):471–82. https://doi.org/10.1159/000510219.

Article  CAS  PubMed  Google Scholar 

Guoxiang H, Hui L, Yong Z, Xunming J, Zhuo C. Association between Cystatin C and SVD in Chinese population. Neurol Sci. 2018;39(12):2197–202. https://doi.org/10.1007/s10072-018-3577-x.

Article  PubMed  Google Scholar 

Yao D, Li S, Jing J, et al. Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population. Stroke. 2022;53(10):3123–32. https://doi.org/10.1161/STROKEAHA.122.039277.

Article  CAS  PubMed  Google Scholar 

Wanggong F, Xiang J, Yang S, Zhang W, Tuerganbieke R. Correlation of serum uric acid, cystatin C and high-sensitivity C-reactive protein with cognitive impairment in lacunar cerebral infarction. Am J Transl Res. 2021;13(6):6717–23.

CAS  PubMed  PubMed Central  Google Scholar 

Kerkhofs D, Wong SM, Zhang E, et al. Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study. Geroscience. 2021;43(4):1643–52. https://doi.org/10.1007/s11357-021-00399-x.